Filing Details

Accession Number:
0001181431-12-014359
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-05 17:37:29
Reporting Period:
2012-03-02
Filing Date:
2012-03-05
Accepted Time:
2012-03-05 17:37:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Inc. HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1342821 Jeff Himawan 21 Waterway
Suite 225
The Woodlands TX 77380
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-02 2,761,477 $3.59 5,064,731 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2012-03-02 690,369 $0.03 690,369 $4.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
690,369 2012-03-02 2017-03-02 No 4 C Indirect
Footnotes
  1. The securities are held directly by Essex Woodlands Health Ventures Fund VII, L.P. (the "Fund"). The Reporting Person is a manager of Essex Woodlands Health Ventures VII, LLC, which is the general partner of Essex Woodlands Health Ventures VII, L.P., the general partner of the Fund. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.